EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Optical studies of drug protein complexes part 2 interaction of phenyl butazone and its analogues with human serum albumin






Molecular Pharmacology 5(3): 244-252

Optical studies of drug protein complexes part 2 interaction of phenyl butazone and its analogues with human serum albumin


(PDF 0-2 workdays service: $29.90)

Accession: 027090164



Related references

Optical studies of drug-protein complexes. II. Interaction of phenylbutazone and its analogues with human serum albumin. Molecular Pharmacology 5(3): 244-252, 1969

Optical studies of drug protein complexes part 4 the interaction of warfarin and dicoumarol with human serum albumin. Molecular Pharmacology 6(1): 1-12, 1970

Optical studies of drug protein complexes part 5 the interaction of phenylbutazone flufenamic acid and dicoumarol with acetyl salicylic acid treated human serum albumin. Molecular Pharmacology 7(3): 229-237, 1971

Optical studies of drug-protein complexes. IV. The interaction of warfarin and dicoumarol with human serum albumin. Molecular Pharmacology 6(1): 1-12, 1970

Optical activity studies of drug--protein complexes. The interaction of acetylsalicylic acid with human serum albumin and myeloma immunoglobulin. Biochemical Pharmacology 27(7): 1043-1047, 1978

Optical studies into the nature of the high affinity binding site of human serum albumin for phenyl butazone. Molecular Pharmacology 16(1): 147-153, 1979

Effect of protein concentration on the binding of drugs to human serum albumin part 1 sulfadiazine salicylate and phenyl butazone. Biochemical Pharmacology 28(6): 751-756, 1979

Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin. Molecular Pharmacology 5(5): 455-462, 1969

Optical studies of drug-protein complexes. V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetylsalicylic acid-treated human serum albumin. Molecular Pharmacology 7(3): 229-237, 1971

Effect of albumin conformation on the binding of phenyl butazone and oxyphen butazone to human serum albumin. Journal of Pharmaceutical Sciences 71(2): 241-244, 1982